secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eledon Pharmaceuticals, Inc. (ELDN)
CIK:        0001404281
Form:       8-K/A
Filed at:   2025-04-14T23:59:59+00:00
Accession:  0000950170-25-053765
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Eledon Pharmaceuticals amends 8-K to correct auditor dismissal period; Crowe served only FY 2024
--------------------------------------------------------------------------------

- Corrects prior 8-K that inadvertently referenced Crowe LLP for fiscal year 2023.
- Audit Committee dismissed Crowe LLP and engaged Deloitte & Touche LLP on April 1, 2025.
- Crowe served as auditor from July 10, 2024 to April 1, 2025; no disagreements or reportable events.
- Deloitte engaged as independent auditor for fiscal year ending December 31, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1404281/000095017025053765/0000950170-25-053765-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1404281/000095017025053765/eldn-20250401.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-053765

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer